Pharmaceutical Technology

MAY 22, 2023

This new facility complements the bioprocess design centre and customer experience centre, the two operational lab facilities of Thermo Fisher with the latest life science, analytical, and bioprocessing technologies. The bioprocess design centre offers expertise in bioprocessing and process scale-up.

Genetic Analysis 147

Genetic Analysis Manufacturing Drugs Vaccine 147

Drug Discovery Today

AUGUST 5, 2021

(Oslo, August 5, 2021) Molecular diagnostics specialist, Genetic Analysis AS (GA) today announced the first publication from the comprehensive HumGut microbiome database has appeared in the leading scientific journal Microbiome.

Genetic Analysis 40

Genetic Analysis Genomics Genome Genetics 40

XTalks

MARCH 7, 2024

Breast Cancer Multiomics: Unified Insights in Tumor Heterogeneity This on-demand webinar introduces a cutting-edge single-cell multiomics method designed for garnering detailed genetic insights into breast cancer. The test accurately identified a range of genetic abnormalities, including trisomies and microdeletions.

Genetics 115

Genetics Hormones Genome Genomics 115

XTalks

JULY 29, 2024

Understanding Late-Onset Pompe Disease Pompe disease, also known as glycogen storage disease type II (GSD2) or acid maltase deficiency, is a rare genetic disorder with an approximate incidence of one in 40,000 births characterized by the deficiency of the enzyme acid alpha-glucosidase (GAA).

Clinical Trials 105

Clinical Trials Clinical Trials Trials Research 105

XTalks

DECEMBER 1, 2020

As the research and medical community learns more about population variances in disease outcomes, whether as a result of regional genetic profiles, socioeconomic factors, or environmental inputs, it’s become necessary to ensure that clinical research trials include broad swaths of global participants.

Clinical Trials 96

Clinical Trials Clinical Trials Trials Clinical Research 96

XTalks

JANUARY 6, 2025

Furthermore, CRISPR/Cas9 presents a promising avenue for overcoming genetic diseases in the near future. CAR-T cell therapies continue to dominate the pipeline for genetically modified cell therapies, with 97 percent of them targeting cancer. By 2025 , 10 to 20 new gene therapies are expected to gain approval each year.

Gene Therapy 111

Gene Therapy RNA Gene Editing Gene 111